Can a Mid-Treatment scan make radiation smarter?

NCT ID NCT03403465

First seen Nov 21, 2025 · Last updated Jun 23, 2026 · Updated 29 times

Summary

This study is testing whether doing a special PET scan during radiation treatment can help doctors adjust the plan to better target tumors and spare healthy tissue. It involves 90 adults with cervical, vulvar, esophageal, or anal cancer. The goal is to see if this approach improves outcomes like tumor control and survival.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Duke University Medical Center

    Durham, North Carolina, 27710, United States

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

FDG PET scan (imaging test)

What this could lead to

If successful, this could show that a mid-treatment PET scan helps doctors personalize radiation therapy, potentially improving tumor control and reducing damage to healthy tissue.

What could go wrong

This is a small, early-phase study focused on gathering information, not proving a new treatment works. The PET scan may not lead to better outcomes for all patients.

Conditions

The condition(s) this trial relates to.

anal canal cancer cervical cancer cervical carcinoma cloacogenic carcinoma esophageal cancer Esophageal Neoplasms Uterine Cervical Neoplasms vulva cancer

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.